Glaxosmithkline Biologicals; Niederlassung Der Smithkline Beecham Pharma GmbH & Co. KG
发明人:
EICHHORN UWE,SAENGER ROLAND HERBERT
申请号：
PL10765603
公开号：
PL2482845T3
申请日:
2010.09.28
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
An inactivated influenza virus preparation is described which comprises a haemagglutinin antigen stabilised in the absence of thiomersal, or at low levels of thiomersal, wherein the haemagglutinin is detectable by a SRD assay. The influenza virus preparation may comprise a micelle modifying excipient, for example &alpha；-tocopherol or a derivative thereof in a sufficient amount to stabilise the haemagglutinin.
